BACKGROUND: Human T-lymphotropic virus type 1 (HTLV-1) and HTLV-2 are prevalent at low levels among US blood donors, but recent data on their prevalence is lacking. METHODS. Data on all first-time blood donors in a large network of US blood centers were examined during 2000-2009. HTLV-1 and HTLV-2 antibodies were measured by enzyme immunoassay (EIA) with confirmation by immunofluorescence or recombinant immunoblot. Prevalence rates were calculated, and odds ratios were assessed using multivariable logistic regression. RESULTS: Among 2 047 740 first-time donors, 104 were seropositive for HTLV-1 (prevalence, 5.1 cases/per 100 000; 95% confidence interval [CI], 4.1-6.1), and 300 were seropositive for HTLV-2 (prevalence, 14.7 cases/per 100 000; 95% CI, 13.0-16.3). The prevalence was lower than reported in the 1990s but stable from 2000 to 2009. HTLV-1 seropositivity was associated with female sex, older age, and black and Asian race/ethnicity. HTLV-2 seropositivity was associated with female sex, older age, nonwhite race/ethnicity, lower educational level, and residence in the western and southwestern United States. CONCLUSIONS: The HTLV-1 and HTLV-2 prevalences among US blood donors has declined since the early 1990s. A higher prevalence of HTLV-2 in the west and southwest may be attributed to endemic foci among Amerindians.
BACKGROUND:Human T-lymphotropic virus type 1 (HTLV-1) and HTLV-2 are prevalent at low levels among US blood donors, but recent data on their prevalence is lacking. METHODS. Data on all first-time blood donors in a large network of US blood centers were examined during 2000-2009. HTLV-1 and HTLV-2 antibodies were measured by enzyme immunoassay (EIA) with confirmation by immunofluorescence or recombinant immunoblot. Prevalence rates were calculated, and odds ratios were assessed using multivariable logistic regression. RESULTS: Among 2 047 740 first-time donors, 104 were seropositive for HTLV-1 (prevalence, 5.1 cases/per 100 000; 95% confidence interval [CI], 4.1-6.1), and 300 were seropositive for HTLV-2 (prevalence, 14.7 cases/per 100 000; 95% CI, 13.0-16.3). The prevalence was lower than reported in the 1990s but stable from 2000 to 2009. HTLV-1 seropositivity was associated with female sex, older age, and black and Asian race/ethnicity. HTLV-2 seropositivity was associated with female sex, older age, nonwhite race/ethnicity, lower educational level, and residence in the western and southwestern United States. CONCLUSIONS: The HTLV-1 and HTLV-2 prevalences among US blood donors has declined since the early 1990s. A higher prevalence of HTLV-2 in the west and southwest may be attributed to endemic foci among Amerindians.
Entities:
Keywords:
HTLV-1; HTLV-2; Human T-lymphotropic virus; United States; blood donors; demographic determinants; prevalence
Authors: Bernadette Catalan-Soares; Anna Bárbara de F Carneiro-Proietti; Fernando Augusto Proietti Journal: Cad Saude Publica Date: 2005-05-02 Impact factor: 1.632
Authors: Diana F Roucoux; Baoguang Wang; Donna Smith; Catharie C Nass; James Smith; Sheila T Hutching; Bruce Newman; Tzong-Hae Lee; Daniel M Chafets; Edward L Murphy Journal: J Infect Dis Date: 2005-03-31 Impact factor: 5.226
Authors: Anna Bárbara F Carneiro-Proietti; Ester C Sabino; Silvana Leão; Nanci A Salles; Paula Loureiro; Moussa Sarr; David Wright; Michael Busch; Fernando A Proietti; Edward L Murphy Journal: AIDS Res Hum Retroviruses Date: 2012-05-03 Impact factor: 2.205
Authors: Y Fukushima; H Takahashi; W W Hall; T Nakasone; S Nakata; P Song; D Dinh Duc; B Hien; X Q Nguyen; T Ngoc Trinh Journal: AIDS Res Hum Retroviruses Date: 1995-05 Impact factor: 2.205
Authors: J E Kaplan; R F Khabbaz; E L Murphy; S Hermansen; C Roberts; R Lal; W Heneine; D Wright; L Matijas; R Thomson; D Rudolph; W M Switzer; S Kleinman; M Busch; G B Schreiber Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1996-06-01
Authors: Michelle T Vo; Roberta Bruhn; Zhanna Kaidarova; Brian S Custer; Edward L Murphy; Evan M Bloch Journal: Transfusion Date: 2015-10-28 Impact factor: 3.157